Risk factors and prognostic implications for pathologic upstaging to T3a after partial nephrectomy-Reference-Cited by-同舟云学术

Risk factors and prognostic implications for pathologic upstaging to T3a after partial nephrectomy

Published:2019-07 Issue:4 Volume:71 Page:
ISSN:0393-2249
Container-title:Minerva Urologica e Nefrologica
language:
Short-container-title:Minerva Urol Nefrol

Author:

Beksac Alp T.,Paulucci David J.,Gul Zeynep,Reddy Balaji N.,Kannappan Muthumeena,Martini Alberto,Sfakianos John P.,Gin Greg E.,Abaza Ronney,Eun Daniel D.,Bhandari Akshay,Hemal Ashok K.,Porter James,Badani Ketan K.

Publisher

Edizioni Minerva Medica

Subject

Urology,Nephrology

Link

https://www.minervamedica.it/pdf.php?cod=R19Y2019N04A0395

Reference20 articles.

1. Renal cancer

2. Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

3. Outcomes of partial nephrectomy for clinical T1b and T2 renal tumors

4. Treatment Management of Small Renal Masses in the 21st Century: A Paradigm Shift

5. Increased use of partial nephrectomy to treat high-risk disease

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes and predictors of clinical T1 renal mass (cT1) upstaged to pathological T3a (pT3a) after partial nephrectomy: A single‐center experience;International Journal of Urology;2023-12-20

2. Patient and tumor characteristics of histological subtypes of renal cell carcinoma and its risk of upstaging to ≥pT3;Urologic Oncology: Seminars and Original Investigations;2023-12

3. A morphology-based nephrometry score to predict pathological upstaging to T3 renal cell carcinoma;Translational Andrology and Urology;2022-12

4. An external validation of the nocera nomogram: Predicting non-organ confined stage of ≥pT3 in cT1 clear cell renal cell carcinoma;Frontiers in Oncology;2022-10-10

5. Effect of Positive Surgical Margins in Patients Who Undergo a Partial Nephrectomy Regarding Recurrence, Overall Survival, Recurrence/Progression-Free Survival, and Metastasis-Free Survival. A Systematic Review and Meta-Analysis;Clinical Genitourinary Cancer;2022-10